Bendamustine and rituximab as induction therapy in both transplant-eligible and -ineligible patients with mantle cell lymphoma.
暂无分享,去创建一个
D. Scott | L. Sehn | K. Savage | C. Freeman | D. Villa | K. Song | C. Toze | A. Gerrie | Wendie den Brok
暂无分享,去创建一个
D. Scott | L. Sehn | K. Savage | C. Freeman | D. Villa | K. Song | C. Toze | A. Gerrie | Wendie den Brok